Top Markets
Coin of the day
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Rang in aandelen #29434
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aandeelprijs
$3.92
Laatst gesynchroniseerd: 2026-07-31
Marktkapitalisatie
$21.16M
Verandering (1 dag)
-0.13%
Verandering (1 jaar)
-48.76%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)

Categorie

Koersgeschiedenis voor Neuphoria Therapeutics Inc. (NEUP)
Hoogste slotkoers: $3.59 op 2026-07-01

Laagste slotkoers: $153.40 op 2021-12-01
Koersgeschiedenis van Neuphoria Therapeutics Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 47.24%
2025 10.82%
2024 -76.55%
2023 -78.13%
2022 -53.72%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$544.11 39.24%
US
$1.02K 56.01%
NL
$144.46 417.59%
US
$117.42 -19.34%
AU
$754.32 8.74%
CH